バイオチップの世界市場の動向・予測 (2022年～2028年)：製品タイプ・技術・用途・地域別

時間・コストの削減のためのラボの小型化や、製造業者による幅広い用途に対応した広範な製品ポートフォリオの提供などの要因がバイオチップ市場の成長を推進しています。

当レポートでは、世界のバイオチップの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査目的・前提因子

第2章 市場概要

第3章 市場力学・法規制・動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• PEST分析
• ポーターのファイブフォース分析

第4章 世界のバイオチップ市場：製品タイプ別

市場シェア分析

• 前年比成長分析
  • DNAチップ
  • タンパク質チップ
  • Lab-on-a-Chip
  • その他（細胞アレイおよび組織アレイ）

第5章 世界のバイオチップ市場：技術別

• 市場シェア分析
• 前年比成長分析
  • マイクロフルイディクス
  • マイクロアレイ

第6章 世界のバイオチップ市場：用途別

市場シェア分析

• 前年比成長分析
  • ゲノミクス
  • プロテオミクス
  • 創薬・開発
  • 体外診断

第7章 世界のバイオチップ市場：地域別

• 市場シェア分析
• 前年比成長分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • アフリカ
  • 中東

第8章 競合情勢

• ヒートマップ分析
• 企業プロファイル
  • Randox Laboratories
  • Fluidigm Corporation
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • ThermoFisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.

第9章 セクション

Biochip technology holds applications in areas such as diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. Microarray or biochip technology could prove beneficial, as prevalence of these diseases is increasing worldwide. Complexity of the technology, necessary resources in terms of manufacturing, and research and development of these products reflects in terms of high prices. Although the product helps in reducing costs incurred in laboratory methods, the biochip technology itself is still costly. Manufacturers and universities are focused on improving technology of the biochips in order to increase the precision of the results while lowering the costs and time. For instance, researchers from Stanford University School of Medicine had developed a method to produce cheap and reusable diagnostic lab-on-a-chip with the help of an inkjet printer, which was worth 1 cent per chip, in 2017.

Market Dynamics

Miniaturization of laboratory facilities to save time and costs and extensive product portfolios with wide number of applications of biochips offered by manufacturer’s drives growth of biochips market. Manufacturers offer technologically advanced products in order to minimize time and costs, and improve research outcomes. For instance, Micralyne, Inc. launched Silicon MicraFluidics technology, a line of standardized microfluidic process technologies, which enabled rapid design and deployment of microfluidic-based products in February 2018. Technological advancements in biochips platform, ongoing research and development to widen the applications, and advantages offered by biochip technologies over conventional laboratory with respect to time, costs, and ease of use is expected to fuel growth of the market.

Key features of the study:

This report provides in-depth analysis of biochips market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global biochips market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the biochips market

Detailed Segmentation:

Global Biochips Market, By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

Global Biochips Market, By Technology:

Microfluidics

Microarray

Global Biochips Market, By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

Global Biochips Market, By Geography:

North America

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

U.S.

Canada

Europe

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

Central Africa

South Africa

North Africa

Company Profiles

Randox Laboratories*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Fluidigm Corporation

Abbott Laboratories

Agilent Technologies, Inc.

ThermoFisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Illumina, Inc.

PerkinElmer, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description

§ Market Definition and Scope

• Executive Summary

§ Market Snippet, By Product Type

§ Market Snippet, By Technology

§ Market Snippet, By Application

§ Market Snippet, By Region

• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics

§ Drivers

§ Restraints

§ Market Opportunities

• PEST Analysis
• PORTER's Five Forces Analysis
• Areas of Overlap- Lab-on-a-Chip, BioMEMS, and μTAS

4. Global Biochips Market, By Product Type, 2017 - 2028 (US$ Mn)

• Introduction

§ Market Share Analysis, 2022 and 2028 (%)

§ Y-o-Y Growth Analysis, 2017 - 2028

§ Segment Trends

• DNA Chips

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• Protein Chips

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• Lab-on-a-Chip

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• Others (Cell Arrays & Tissue Arrays)

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Biochips Market, By Technology, 2017 - 2028 (US$ Mn)

• Introduction

§ Market Share Analysis, 2022 and 2028 (%)

§ Y-o-Y Growth Analysis, 2017 - 2028

§ Segment Trends

• Microfluidics

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• Microarray

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Biochips Market, By Application, 2017 - 2028 (US$ Mn)

• Introduction

§ Market Share Analysis, 2022 and 2028 (%)

§ Y-o-Y Growth Analysis, 2017 - 2028

§ Segment Trends

• Genomics

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• Proteomics

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• Drug Discovery & Development

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

• In-Vitro Diagnostics

§ Introduction

§ Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Biochips Market, By Regions, 2017 - 2028 (US$ Mn)

• Introduction

§ Market Share Analysis, By Region, 2022 and 2028 (%)

§ Y-o-Y Growth Analysis, For Regions, 2017 - 2028

• North America

§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)

§ U.S.

§ Canada

• Europe

§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)

§ U.K.

§ Germany

§ Italy

§ France

§ Spain

§ Russia

§ Rest of Europe

• Asia Pacific

§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)

§ China

§ India

§ Japan

§ ASEAN

§ Australia

§ South Korea

§ Rest of APAC

• Latin America

§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)

§ Brazil

§ Mexico

§ Argentina

§ Rest of Latin America

• Africa

§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)

§ Central Africa

§ South Africa

§ North Africa

• Middle East

§ Market Size and Forecast, By Product Type, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Technology, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Application, 2017 - 2028 (US$ Mn)

§ Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)

§ GCC

§ Israel

§ Rest of Middle East

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles

§ Randox Laboratories

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ Fluidigm Corporation

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ Abbott Laboratories

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ Agilent Technologies, Inc.

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ ThermoFisher Scientific, Inc.

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ Bio-Rad Laboratories, Inc.

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ Illumina, Inc.

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

§ PerkinElmer, Inc.

§ Company Overview

§ Product Portfolio

§ Key Developments

§ Financial Performance

§ Strategies

9. Section

• References
• Research Methodology
• About Us and Sales Contact